iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionStratos Wealth Advisors, LLC
Latest Disclosed Ownership3,970 shares
Latest Disclosed Value $ 670,382
Stratos Wealth Advisors, LLC reports 0.89% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On April 28, 2026 - Stratos Wealth Advisors, LLC filed a 13F-HR form disclosing ownership of 3,970 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $670,382 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 20, 2026 disclosing 3,935 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 0.89% during the quarter. The current value of the position is $520,269 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,970 35 0.89 670 0.90 0.0411
2026-01-20 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,935 -51 -1.28 664 15.48 0.0321
2025-11-06 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,986 154 4.02 575 18.80 0.0277
2025-07-29 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,832 -62 -1.59 485 -2.81 0.0256
2025-04-30 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,894 1 0.03 498 -3.11 0.0272
2025-01-27 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,893 -109 -2.72 515 -11.68 0.0246
2024-10-17 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 4,002 0 0.00 583 6.01 0.0267
2024-07-24 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 4,002 -23 -0.57 549 -0.54 0.0272
2024-04-16 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 4,025 222 5.84 552 6.98 0.0327
2024-01-24 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,803 -621 -14.04 517 -4.62 0.0297
2023-10-24 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 4,424 -280 -5.95 541 -9.38 0.0357
2023-07-18 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 4,704 -89 -1.86 597 -3.55 0.0423
2023-04-27 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 4,793 43 0.91 619 -0.64 0.0476
2023-01-19 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 4,750 949 24.97 624 40.00 0.0520
2022-10-24 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,801 -19 -0.50 445 -0.89 0.0468
2022-07-22 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,820 -234 -5.77 449 -14.96 0.0407
2022-04-26 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 4,054 -7,578 -65.15 528 -70.25 0.0429
2022-01-14 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 11,632 -5,876 -33.56 1,775 -37.30 0.1278
2021-10-19 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 17,508 -4,883 -21.81 2,831 -22.73 0.2419
2021-07-19 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 22,391 -1,593 -6.64 3,664 1.47 0.3242
2021-04-27 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 23,984 5,860 32.33 3,611 31.50 0.3834
2021-01-29 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 18,124 4,570 33.72 2,746 49.65 0.3786
2020-10-29 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 13,554 9,564 239.70 1,835 236.70 0.4470
2020-07-28 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 3,990 978 32.47 545 67.69 0.1671
2020-05-04 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 3,012 -65 -2.11 325 -12.40 0.2302
2020-01-29 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 3,077 -106 -3.33 371 17.03 0.2104
2019-11-12 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 3,183 -329 -9.37 317 -17.23 0.1213
2019-08-06 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 3,512 8 0.23 383 -2.30 0.1528
2019-05-07 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 3,504 -220 -5.91 392 9.19 0.2119
2019-02-12 2018-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 3,724 3,724 359 0.2395
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.